<DOC>
	<DOCNO>NCT01723969</DOCNO>
	<brief_summary>The EORTC GastroIntestinal Tract Cancer Group EORTC HeadQuarters wish set European screening platform advance colo-rectal cancer ( CRC ) patient . The goal screen platform provide quick access new drug patient offer new structure clinical trial . Currently challenge clinical question arise molecular sub-division CRC would theoretically allow inhibit specific , altered pathway patient . A major problem trial `` personalized medicine '' low frequency different mutation require high effort screen identify patient . The EORTC CRC screen platform hopefully offer feasible efficient way characterize patient molecular basis tumor allow offer rapid preferential participation clinical study new drug target specific pathway alteration .</brief_summary>
	<brief_title>Screening Platform Clinical Trials Advanced Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Colorectal cancer ( advanced metastatic ) Before patient registration , write informed consent must give accord ICH/GCP , national/local regulation . Absence patient 's consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>